Originally Posted on Cigna GNS Healthcare (GNS), a leading precision medicine company, today announced a $23 million Series D fundraising round, led by Cigna Ventures, a strategic corporate venture capital partner and a wholly-owned indirect subsidiary of Cigna Corporation. Joining the Cigna Ventures-led funding round were Amgen Ventures, Celgene, Echo…
